
Welcome to AbXtract
A new cloud based software platform specifically designed by scientists working in antibody discovery to rapidly generate antibody leads from next generation sequencing data.
December 02, 2021

Specifica CTO, Sara D’Angelo, gives a tour of Specifica’s new facilities.
In this brief tour of Specifica’s custom, state of the art laboratories, Sara D’Angelo, Specifica’s CTO, explains the rationale and thinking behind the laboratory design, optimized for all aspects of…
July 21, 2021

Specifica CSO, Andrew Bradbury, participates in Covid19 Antibody Roundtable Discussion
In a roundtable discussion, three experts bring perspectives on different methods for generating antibodies, including from naive libraries, patients, and immunizations. They discuss how the COVID-19 pandemic has highlighted the…
April 21, 2021

Specifica CSO, Andrew Bradbury, participates in this Miltenyi webcast on the importance of recombinant antibodies.
Specifica CSO, Andrew Bradbury, participates in this Miltenyi webcast on the importance of recombinant antibodies.Read the full article HERE.
June 03, 2018